MVK p.Val377Ile

Variant summary

Our verdict is Likely pathogenic.
+9 Likely Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 9 classification points (ACMG Germline Pathogenicity v2019). PS3PP1PP5_Strong

The NM_000431.4(MVK):c.1129G>A (p.Val377Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.0021 (AC=3,382) in the gnomAD database across 1,612,856 control chromosomes, including 4 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.00243. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000032940: MVK enzyme activity in patient lymphocytes was below 1%." and additional evidence is available in ClinVar. This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: 𝑓 0.0015 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0022 ( 3 hom. )

Consequence

MVK
NM_000431.4 missense

Predictors

2
7
10
REVEL: 0.55 : Uncertain

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:53O:3

Conservation

PhyloP100: 5.08

Publications

124 publications found
Genes affected
MVK (HGNC:7530): (mevalonate kinase) This gene encodes the peroxisomal enzyme mevalonate kinase. Mevalonate is a key intermediate, and mevalonate kinase a key early enzyme, in isoprenoid and sterol synthesis. Mevalonate kinase deficiency caused by mutation of this gene results in mevalonic aciduria, a disease characterized psychomotor retardation, failure to thrive, hepatosplenomegaly, anemia and recurrent febrile crises. Defects in this gene also cause hyperimmunoglobulinaemia D and periodic fever syndrome, a disorder characterized by recurrent episodes of fever associated with lymphadenopathy, arthralgia, gastrointestinal dismay and skin rash. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
MVK Gene-Disease associations (from GenCC):
  • porokeratosis 3, disseminated superficial actinic type
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • hyperimmunoglobulinemia D with periodic fever
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • mevalonate kinase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • mevalonic aciduria
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia, G2P
  • disseminated superficial actinic porokeratosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • porokeratosis of Mibelli
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000431.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Likely_pathogenic. The variant received 9 points.

PS3Functional studies show damaging effect
Well-established functional study supports damaging effect (PS3); SCV000032940: MVK enzyme activity in patient lymphocytes was below 1%.; SCV000279123: Published functional studies indicate that p.(V377I) leads to a decrease in enzyme activity and decreased stability when expressed in E. coli (Houten et al., 1999); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23692791, 12634869, 21228398, 23979089, 24561416, 25708585, 30030262, 24177804, 19011501, 34525209, 34809655, 24360083, 24470648, 10369262, 10369261, 15188372, 26300074, 26633545, 26977311, 11313769, 26116953, 15657603, 27899390, 13130485, 26990548, 28638818, 18839211, 24716072, 15536479, 25866490, 24233262, 22038276, 30609409, 26620804, 29290516, 10896296, 30148429, 31474985, 30783801, 31664448, 34573280, 34426522, 34054914, 31589614, 32822427, 32888943, 35418827, 33917151, 35163749, 17105862, 26986117, 35387795, 35753512); SCV000538050: Functional studies have shown reduced or undetectable mevalonate kinase activity and protein expression in affected individuals, indicating this variant likely affects protein stability and function (Houten et al., 1999).; SCV000712172: It has been demonstrated to lead to reduced enzymatic ac tivity in vitro (Houten 1999).; SCV001548926: However, functional studies expressing cDNA constructs containing the V325I variant in E. coli have demonstrated decreased mevalonate kinase (MK) protein activity compared to wildtype (Houten_1999_PMID:10369261). Decreased MK activity was also found in lymphocytes and fibroblasts from patients with the V325I variant (Houten_1999_PMID:10369261).; (+9 more)
PP1Cosegregation with disease
ClinVar submission reports cosegregation with disease (PP1); SCV000032940: (2001) detected the V377I mutation, including one sibship with homozygosity.; SCV000032940: The mutations were identified by sequencing of the MVK gene, and the parents of both patients were mutation carriers.; SCV000634151: It has also been observed to segregate with disease in related individuals.; SCV002526420: The variant co-segregated with disease in multiple affected family members (PMID: 32822427; 17105862) - PP1 andallele frequency is greater than expected for disorder - BS1.; SCV003928976: The variant allele was found at a frequency of 0.0016 in 249414 control chromosomes, predominantly at a frequency of 0.0023 within the Non-Finnish European subpopulation in the gnomAD database. c.1129G>A has been reported in the literature in multiple individuals affected with Hyper-IgD syndrome (HIDS), including in cases where it was in trans with a pathogenic variant and it has been found to segregate with disease (e.g. Houten_1999, Cuisset_2001, Govindaraj_2020).; (+1 more)
PP5Reputable source reports pathogenic
ClinVar 2-star pathogenic — strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). ClinVar submissions strongly and reliably favor pathogenicity (53/53 total P/LP)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000431.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

MVK NM_000431.4
MANE Select
HGVSc / HGVSpc.1129G>Ap.Val377Ile
Exon rankExon 11 of 11
missense
Prot: NP_000422.1
MVK NM_001414512.1
HGVSc / HGVSpc.1204G>Ap.Val402Ile
Exon rankExon 12 of 12
missense
Prot: NP_001401441.1
MVK NM_001114185.3
HGVSc / HGVSpc.1129G>Ap.Val377Ile
Exon rankExon 11 of 11
missense
Prot: NP_001107657.1

Ensembl Transcripts

MVK ENST00000228510.8
MANE Select
HGVSc / HGVSpc.1129G>Ap.Val377Ile
Exon rankExon 11 of 11
missense
Prot: ENSP00000228510
MVK ENST00000984944.1
HGVSc / HGVSpc.1180G>Ap.Val394Ile
Exon rankExon 11 of 11
missense
Prot: ENSP00000654761
MVK ENST00000546277.7
HGVSc / HGVSpc.1129G>Ap.Val377Ile
Exon rankExon 11 of 11
missense
Prot: ENSP00000438153

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.00147
AC:223
Hom:1
AN:152196
Cov:33
GnomAD2 exomes
AF: 0.00158
AC:393
AN:249414
GnomAD4 exome
AF: 0.00216
AC:3159
Hom:3
AN:1460542
Cov:31
GnomAD4 genome
AF: 0.00146
AC:223
Hom:1
AN:152314
Cov:33
TOPMed (Bravo)
AF: 0.00134
AC:354
Hom:0
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00162
AC:765
Hom:1
AN:471894
Local & regional cohorts 7 sources
ABraOM SABE-WGS-1171
AF: 0.00256
AC:6
Hom:0
AN:2342
ChinaMAP Phase 1
AF: 0.0000985
ESP6500 (Exome Variant Server)
AF: 0.00169
AC:22
AN:13006
Qatari Genome
AF: 0.00320
AC:6
AN:1868
Turkish Variome
AF: 0.00360
AC:24
Hom:0
AN:6662
UK10K
AF: 0.00357
AC:27
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.000112
AC:1
Hom:0
AN:8960
Showing 13 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
ASC
(Autism)
0.00144 *1611112 0.00131 *2317618
BipEx
(Bipolar disorder (including schizoaffective))
0.00236 6728420 0.00194 5628844
Epi25
(Epilepsy)
0.00176 7441958 0.00199 13366888
SCHEMA
(Schizophrenia)
0.00116 136117240 0.00113 206181816
Showing 4 cohortsAllele count / allele number. *AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
19
-
-
Hyperimmunoglobulin D with periodic fever (19)
16
-
-
not provided (16)
5
-
-
MVK-related disorder (5)
3
-
-
Hyperimmunoglobulin D with periodic fever;C1867981:Porokeratosis 3, disseminated superficial actinic type;C1959626:Mevalonic aciduria (5)
3
-
-
Mevalonic aciduria (3)
2
-
-
Hyperimmunoglobulin D with periodic fever;C1959626:Mevalonic aciduria (3)
1
-
-
Autoinflammatory syndrome (1)
1
-
-
autosomal recessive MVK-related disorders (1)
1
-
-
Inborn genetic diseases (1)
1
-
-
Porokeratosis 3, disseminated superficial actinic type (1)
1
-
-
Retinal dystrophy (1)

Computational Scores

AlphaGenome AVI
Benign7.2
AlphaMissense
Benign0.097
BayesDel_addAF
Benign-0.063T
BayesDel_noAF
Pathogenic0.14
CADD
Benign14
DANN
Uncertain0.98
DEOGEN2
Benign0.24T
Eigen
Benign-0.41
Eigen_PC
Benign-0.37
FATHMM_MKL
Uncertain0.93D
FuncVEP CTI
Benign0.023
GPN-Star LLR
N/A-2.4
GPN-Star score
N/A2.4
LIST_S2
Benign0.83T
M_CAP
Uncertain0.086D
MetaRNN
Benign0.020T
MetaSVM
Uncertain0.071D
Mutation Taster
N/A11/89disease causing (ClinVar)
MutationAssessor
Uncertain2.0M
PhyloP100
Uncertain5.1
popEVE
Benign-3.1
PrimateAI
Benign0.29T
PROVEAN
Benign-0.86N
REVEL
Uncertain0.55
Sift
Benign0.10T
Sift4G
Uncertain0.036D
Varity_R
N/A0.095
VESM-3B
Benign-6.2
Showing 28 of 28 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.